These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29094937)

  • 1. Structure-Based Design and Discovery of New M
    Fish I; Stößel A; Eitel K; Valant C; Albold S; Huebner H; Möller D; Clark MJ; Sunahara RK; Christopoulos A; Shoichet BK; Gmeiner P
    J Med Chem; 2017 Nov; 60(22):9239-9250. PubMed ID: 29094937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insight into active muscarinic receptors with the novel radioagonist [³H]iperoxo.
    Schrage R; Holze J; Klöckner J; Balkow A; Klause AS; Schmitz AL; De Amici M; Kostenis E; Tränkle C; Holzgrabe U; Mohr K
    Biochem Pharmacol; 2014 Aug; 90(3):307-19. PubMed ID: 24863257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor.
    Miao Y; Goldfeld DA; Moo EV; Sexton PM; Christopoulos A; McCammon JA; Valant C
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5675-84. PubMed ID: 27601651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonists with supraphysiological efficacy at the muscarinic M2 ACh receptor.
    Schrage R; Seemann WK; Klöckner J; Dallanoce C; Racké K; Kostenis E; De Amici M; Holzgrabe U; Mohr K
    Br J Pharmacol; 2013 May; 169(2):357-70. PubMed ID: 23062057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrine-xanomeline and tacrine-iperoxo hybrid ligands: Synthesis and biological evaluation at acetylcholinesterase and M
    Maspero M; Volpato D; Cirillo D; Yuan Chen N; Messerer R; Sotriffer C; De Amici M; Holzgrabe U; Dallanoce C
    Bioorg Chem; 2020 Mar; 96():103633. PubMed ID: 32032848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design of partial agonists for the muscarinic m1 acetylcholine receptor.
    Chen X; Klöckner J; Holze J; Zimmermann C; Seemann WK; Schrage R; Bock A; Mohr K; Tränkle C; Holzgrabe U; Decker M
    J Med Chem; 2015 Jan; 58(2):560-76. PubMed ID: 25478907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Ethylmaleimide differentiates between the M
    Etscheid J; Mohr K; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Nov; 391(11):1295-1299. PubMed ID: 30032313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchodilator activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a potent, long-acting, and selective muscarinic M3 receptor antagonist.
    Villetti G; Pastore F; Bergamaschi M; Bassani F; Bolzoni PT; Battipaglia L; Amari G; Rizzi A; Delcanale M; Volta R; Cenacchi V; Cacciani F; Zaniboni M; Berti F; Rossoni G; Harrison S; Petrillo P; Santoro E; Scudellaro R; Mannini F; Geppetti PA; Razzetti R; Patacchini R; Civelli M
    J Pharmacol Exp Ther; 2010 Dec; 335(3):622-35. PubMed ID: 20805306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites.
    Schober DA; Croy CH; Xiao H; Christopoulos A; Felder CC
    Mol Pharmacol; 2014 Jul; 86(1):116-23. PubMed ID: 24807966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites.
    Del Bello F; Bonifazi A; Quaglia W; Mazzolari A; Barocelli E; Bertoni S; Matucci R; Nesi M; Piergentili A; Vistoli G
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3255-9. PubMed ID: 24980056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists.
    Messer WS; Abuh YF; Liu Y; Periyasamy S; Ngur DO; Edgar MA; El-Assadi AA; Sbeih S; Dunbar PG; Roknich S; Rho T; Fang Z; Ojo B; Zhang H; Huzl JJ; Nagy PI
    J Med Chem; 1997 Apr; 40(8):1230-46. PubMed ID: 9111297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enantiomeric N-methyl-4-piperidyl benzilates as muscarinic receptor ligands: Radioligand binding studies and docking studies to models of the three muscarinic receptors M1, M2 and M3.
    Selent J; Brandt W; Pamperin D; Göber B
    Bioorg Med Chem; 2006 Mar; 14(6):1729-36. PubMed ID: 16290166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting effects of allosteric and orthosteric agonists on m1 muscarinic acetylcholine receptor internalization and down-regulation.
    Thomas RL; Langmead CJ; Wood MD; Challiss RA
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1086-95. PubMed ID: 19767446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct Agonist Regulation of Muscarinic Acetylcholine M2-M3 Heteromers and Their Corresponding Homomers.
    Aslanoglou D; Alvarez-Curto E; Marsango S; Milligan G
    J Biol Chem; 2015 Jun; 290(23):14785-96. PubMed ID: 25918156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorination of Photoswitchable Muscarinic Agonists Tunes Receptor Pharmacology and Photochromic Properties.
    Agnetta L; Bermudez M; Riefolo F; Matera C; Claro E; Messerer R; Littmann T; Wolber G; Holzgrabe U; Decker M
    J Med Chem; 2019 Mar; 62(6):3009-3020. PubMed ID: 30827105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M2 and M3 muscarinic receptor activation of urinary bladder contractile signal transduction. I. Normal rat bladder.
    Braverman AS; Tibb AS; Ruggieri MR
    J Pharmacol Exp Ther; 2006 Feb; 316(2):869-74. PubMed ID: 16243961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dioxane and oxathiane nuclei: suitable substructures for muscarinic agonists.
    Piergentili A; Quaglia W; Giannella M; Del Bello F; Bruni B; Buccioni M; Carrieri A; Ciattini S
    Bioorg Med Chem; 2007 Jan; 15(2):886-96. PubMed ID: 17084634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
    Pei XF; Gupta TH; Badio B; Padgett WL; Daly JW
    J Med Chem; 1998 Jun; 41(12):2047-55. PubMed ID: 9622546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M2 and M3 muscarinic receptor activation of urinary bladder contractile signal transduction. II. Denervated rat bladder.
    Braverman AS; Doumanian LR; Ruggieri MR
    J Pharmacol Exp Ther; 2006 Feb; 316(2):875-80. PubMed ID: 16243962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of muscarinic M1 receptors by orthosteric and allosteric ligands.
    Davis CN; Bradley SR; Schiffer HH; Friberg M; Koch K; Tolf BR; Bonhaus DW; Lameh J
    BMC Pharmacol; 2009 Dec; 9():14. PubMed ID: 19951444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.